ADMA News and Press, ADMA Biologics Inc From 11/11/21

After the fifth consecutive revenue beat posted by the company with its Q3 2021 financials, Raymond James has upgraded ADMA Biologics (ADMA +14.3%) to Strong Buy from Outperform. The analysts led by Elliot Wilbur highlight a sequential improvement in its topline and a quarterly gros...

Fossil Group (NASDAQ:FOSL) +32% on Q3 earnings. Babylon (NYSE:BBLN) +28%. Affirm Holdings (NASDAQ:AFRM) +27% on FQ1 earnings. Opendoor Technologies (NASDAQ:OPEN) +18% on Q3 earnings. Society Pass (NASDAQ:SOPA) +19%. ReWalk Robotics (NASDAQ:RWLK) +16% on Q3 earnings. Lordstown Motors...

Image source: The Motley Fool. ADMA Biologics Inc (NASDAQ: ADMA) Q3 2021 Earnings Call Nov 10, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: ADMA Biologics Inc (ADMA) Q3 2021 Earnings Call Transcript

ADMA Biologics, Inc. (ADMA) Q3 2021 Earnings Conference Call November 10, 2021, 16:30 ET Company Participants Skyler Bloom - Director, IR & Corporate Strategy Adam Grossman - Co-Founder, President, CEO & Director Brian Lenz - EVP & CFO Conference Call Participants Kristen Kluska -...

Generated Record Total Revenues of $20.7 Million in the Third Quarter 2021, a 101% Increase Over Third Quarter 2020 Achieved First-Time Positive Gross Profit Narrowed Net Losses Quarter-Over-Quarter Management to Host Conference Call and Webcast Today at 4:30 p.m...

OTCQX:ACRGF, ADMA, AEVA, DADAAMPE, AMWL, APP, APPH, ASND, ATO, OTCPK:ATUSF, AZUL, BANX, BARK, BIOL, BKEP, BMBL, BOXL, BRFS, BRKS, BROS, BSQR, BW, BYND, BZH, CBAY, CCCS, CCMP, CGRN, CLSD, CLVR, CRCT, CYCC, DARE, DGII, DIS, EDRY, EGLX, ELMS, ENS, EVOK, FICO, FIGS, FOSL, FSM, GAU, GDRX, GEVO, OT...

RAMSEY, N.J. and BOCA RATON, Fla., Nov. 03, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived bi...

ADMA has been trading in a downward trajectory over the past few years. ADMA's stock price has taken a beating from several equity offerings as the business continues to invest in the future. ADMA has positioned itself to perform well and insiders have been putting their money whe...

RAMSEY, N.J. and BOCA RATON, Fla., Oct. 25, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced the closing of its previously...

Are These 3 Penny Stocks Worth Watching Right Now Right now, there is a lot of action in the stock market with both penny stocks and blue chips. The most popular stock in the past day or so has become DWAC stock. If you’re not familiar, Digital World Acquisition Corp. ( NASDAQ:...